Yi Zhang

7 ta ish

Zhengzhou University

1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

   Fei Zhou, Ting Yu, Ronghui Du +16

   MaqolaOAOchiq kirish202013 iqtibos

   ABIABI:AkademIndex/2026.other.042529

2. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

   Yeming Wang, Dingyu Zhang, Guanhua Du +43

   Maqola20204 iqtibos

   ABIABI:AkademIndex/2026.other.581935

3. Roles of IFN-γ in tumor progression and regression: a review

   Dragica Jorgovanović, Mengjia Song, Liping Wang +1

   Sharh maqola20204 iqtibos

   ABIABI:AkademIndex/2026.other.816527

4. RETRACTED ARTICLE: miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer

   Jing Sun, Xin Cai, Mingo M. H. Yung +14

   Maqola20183 iqtibos

   ABIABI:AkademIndex/2026.other.304871

5. Adenosine signaling in tumor-associated macrophages and targeting adenosine signaling for cancer therapy

   Lei Yang, Yi Zhang, Li Yang

   Sharh maqola20243 iqtibos

   ABIABI:AkademIndex/2026.other.769111

6. Biomedical Applications of Zinc Oxide Nanomaterials

   Yi Zhang, Tapas R. Nayak, Hao Hong +1

   Sharh maqolaOAOchiq kirish20132 iqtibos

   ABIABI:AkademIndex/2026.other.008159

7. Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy

   Jianbo Jia, Yi Zhang, Xin Yan +3

   Sharh maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.400316